80 research outputs found
Levering van roerende zaken door middel van een zakenrechtelijk waardepapier
De levering van roerende zaken door middel van een zakenrechtelijke waardepapier heeft zich in de loop er eeuwen ontwikkeld van een leveringsvorm die haar grondslag en verklaring vond in het handelsgewoonterecht tot een dogmatisch leerstuk dat zijn plaats vindt in het commune privaatrecht. Deze ontwikkeling heeft er in de eerste plaats toe geleid dat de levering door middel van een zakenrechtelijk waardepapier thans steunt op een vijftal wettelijke bepalingen, waarin wordt bepaald dat de levering van het papier geldt als levering van de zaken. ...
Zie: Samenvattende slotbeschouwing
Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro
In a substantial part of adrenal adenomas and hyperplasias from patients
with Cushing's syndrome, cortisol production is controlled by the
expression of aberrant hormone receptors on adrenocortical cells. We
present in vivo and in vitro data of two patients with a LH-responsive
Cushing's syndrome based on ACTH-independent bilateral adrenal
hyperplasia. Patients 1 and 2 are women who presented with Cushing's
syndrome and bilateral adrenal hyperplasia. Endocrine testing demonstrated
absence of cortisol diurnal rhythm, insufficient cortisol suppression
after 1 mg dexamethasone orally, and undetectable ACTH levels in both
patients. Both patients were treated by laparoscopic biadrenalectomy. In
in vivo testing, in patients 1 and 2, a profound cortisol rise was found
after administration of GnRH [change in cortisol (Delta F), 118 and 106%,
respectively], human CG (Delta F, 133 and 44%), LH (Delta F, 73 and 43%),
ACTH (Delta F, 89 and 181%), and the 5-hydroxy-tryptamine receptor type 4
(5-HT(4)) agonists cisapride (Delta F, 141 and 148%) and metoclopramide
(Delta F, 189 and 95%). In in vitro testing, adrenal cells from patient 2
responded, in a dose-dependent fashion, with cortisol production after
exposure to human CG (Delta F, 45%), cisapride (Delta F, 68%), and
metoclopramide (Delta F, 81%). ACTH induced cortisol production by cells
from both patients (Delta F, 135 and 159%). In receptor studies, LH
receptor mRNA was demonstrated in adrenal tissue of both patients but also
in control adrenal tissue of two patients with persisting
pituitary-dependent Cushing's syndrome treated by biadrenalectomy. In
neither patient were mutations found in the ACTH receptor gene.
LH-responsive Cushing's syndrome associated with bilateral adrenal
hyperplasia may result from aberrant (or possibly increased) adrenal LH
receptor expression. This variant is further characterized by adrenal
responsiveness to 5-HT4 receptor agonists, po
Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R)
Bariatric surgery for hypothalamic obesity in craniopharyngioma patients: a retrospective, matched case-control study
Context: Craniopharyngioma is a sellar tumor associated with high rates of pituitary deficiencies (similar to 98%) and hypothalamic obesity (similar to 50%).Objective: This work aims to determine the efficacy regarding long-term weight loss after bariatric surgery in obese craniopharyngioma patients with hypothalamic dysfunction.Methods: This retrospective, case-control, multicenter, international study included obese craniopharyngioma patients (N=16; of whom 12 are women) with a history of bariatric surgery (12 Roux-en-Y gastric bypass, 4 sleeve gastrectomy; median age 21 years [range, 15-52 years], median follow-up 5.2 years [range, 2.0-11.3 years]) and age/sex/surgery/body mass index-matched obese controls (N=155). Weight loss and obesity-related comorbidities up to 5 years after bariatric surgery were compared and changes in hormonal replacement therapy evaluated.Results: Mean weight loss at 5-year follow-up was 22.0% (95% CI, 16.1%-27.8%) in patients vs 29.5% (95% CI, 28.0%-30.9%) in controls (P=.02), which was less after Roux-en-Y gastric bypass (22.7% [16.9%-28.5%] vs 32.0% [30.4%-33.6%]; P=.003) but at a similar level after sleeve gastrectomy (21.7% [-1.8% to 45.2%] vs 21.8% [18.2%-25.5%]; P=.96). No major changes in endocrine replacement therapy were observed after surgery. One patient died (unknown cause). One patient had long-term absorptive problems.Conclusion: Obese patients with craniopharyngioma had a substantial mean weight loss of 22% at 5-year follow-up after bariatric surgery, independent of type of bariatric surgery procedure. Weight loss was lower than in obese controls after Roux-en-Y gastric bypass. Bariatric surgery appears to be effective and relatively safe in the treatment of obese craniopharyngioma patients.Development and application of statistical models for medical scientific researc
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups. The Pituitary Society coordinated the Pituitary Neoplasm Nomenclature (PANOMEN) workshop to address the topic. Experts in pituitary developmental biology, pathology, neurosurgery, endocrinology, and oncology, including representatives nominated by the Endocrine Society, European Society of Endocrinology, European Neuroendocrine Association, Growth Hormone Research Society, and International Society of Pituitary Surgeons. Clinical epidemiology, disease phenotype, management, and prognosis of pituitary adenomas differ from that of most NETs. The vast majority of pituitary adenomas are benign and do not adversely impact life expectancy. A nomenclature change to PitNET does not address the main challenge of prognostic prediction, assigns an uncertain malignancy designation to benign pituitary adenomas, and may adversely affect patients. Due to pandemic restrictions, the workshop was conducted virtually, with audiovisual lectures and written précis on each topic provided to all participants. Feedback was collated and summarized by Content Chairs and discussed during a virtual writing meeting moderated by Session Chairs, which yielded an evidence-based draft document sent to all participants for review and approval. There is not yet a case for adopting the PitNET nomenclature. The PANOMEN Workshop recommends that the term adenoma be retained and that the topic be revisited as new evidence on pituitary neoplasm biology emerges
De (on)overdraagbaarheid van de revindicatie:Enige opmerkingen over par. 931 BEB vanuit het perspectief van het Nederlandse recht
- …